Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells

Youde Jiang, Jena J SteinleDepartment of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI, USAPurpose: Inflammation has been strongly associated with retinal damage in diseases such as diabetic retinopathy. Several studies have reported that high...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jiang Y, Steinle JJ
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
PKR
Acceso en línea:https://doaj.org/article/de5c849afd984451972265bd3eae937e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:de5c849afd984451972265bd3eae937e
record_format dspace
spelling oai:doaj.org-article:de5c849afd984451972265bd3eae937e2021-12-02T03:06:44ZEpac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells1178-7031https://doaj.org/article/de5c849afd984451972265bd3eae937e2019-06-01T00:00:00Zhttps://www.dovepress.com/epac1-inhibits-pkr-to-reduce-nlrp3-inflammasome-proteins-in-retinal-en-peer-reviewed-article-JIRhttps://doaj.org/toc/1178-7031Youde Jiang, Jena J SteinleDepartment of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI, USAPurpose: Inflammation has been strongly associated with retinal damage in diseases such as diabetic retinopathy. Several studies have reported that high glucose exposure induces damage to the retinal vasculature. We and others have shown that high glucose can activate the NOD-like receptor family, pyrin domain containing family member 3 (NLRP3) pathway, leading to increased levels of cleaved caspase 1 and IL-1β to activate a number of inflammatory pathways in the retina.Methods: We used retinal endothelial cells grown in normal (5 mM) or high (25 mM) glucose or retinal lysates from endothelial cell-specific knockout mice for exchange protein activated by cAMP 1 (Epac1). Human recombinant protein kinase R (PKR) or C16, a PKR inhibitor, was used on the cells to dissect PKR and NLRP3 signaling.Results: Using retinal endothelial cells (REC) in high glucose and whole retinal lysates from endothelial cell-specific knockout of Epac1, we demonstrate that Epac1 regulates PKR phosphorylation. Using an Epac1 agonist or PKR inhibition with C16, we demonstrated that loss of PKR resulted in reduced NLRP3, cleaved caspase 1, and IL-1β levels. Furthermore, despite the addition of recombinant human PKR, Epac1 was still able to significantly reduce NLRP3 signaling.Conclusion: Overall, these studies demonstrated that PKR regulates the NLRP3 inflammasome in REC, and that Epac1 inhibition of PKR can reduce activation of the NLRP3 inflammasome.Keywords: inflammasome, NLRP3, PKR, retinal endothelial cellsJiang YSteinle JJDove Medical PressarticleinflammasomeNLRP3PKRretinal endothelial cellsPathologyRB1-214Therapeutics. PharmacologyRM1-950ENJournal of Inflammation Research, Vol Volume 12, Pp 153-159 (2019)
institution DOAJ
collection DOAJ
language EN
topic inflammasome
NLRP3
PKR
retinal endothelial cells
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
spellingShingle inflammasome
NLRP3
PKR
retinal endothelial cells
Pathology
RB1-214
Therapeutics. Pharmacology
RM1-950
Jiang Y
Steinle JJ
Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
description Youde Jiang, Jena J SteinleDepartment of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI, USAPurpose: Inflammation has been strongly associated with retinal damage in diseases such as diabetic retinopathy. Several studies have reported that high glucose exposure induces damage to the retinal vasculature. We and others have shown that high glucose can activate the NOD-like receptor family, pyrin domain containing family member 3 (NLRP3) pathway, leading to increased levels of cleaved caspase 1 and IL-1β to activate a number of inflammatory pathways in the retina.Methods: We used retinal endothelial cells grown in normal (5 mM) or high (25 mM) glucose or retinal lysates from endothelial cell-specific knockout mice for exchange protein activated by cAMP 1 (Epac1). Human recombinant protein kinase R (PKR) or C16, a PKR inhibitor, was used on the cells to dissect PKR and NLRP3 signaling.Results: Using retinal endothelial cells (REC) in high glucose and whole retinal lysates from endothelial cell-specific knockout of Epac1, we demonstrate that Epac1 regulates PKR phosphorylation. Using an Epac1 agonist or PKR inhibition with C16, we demonstrated that loss of PKR resulted in reduced NLRP3, cleaved caspase 1, and IL-1β levels. Furthermore, despite the addition of recombinant human PKR, Epac1 was still able to significantly reduce NLRP3 signaling.Conclusion: Overall, these studies demonstrated that PKR regulates the NLRP3 inflammasome in REC, and that Epac1 inhibition of PKR can reduce activation of the NLRP3 inflammasome.Keywords: inflammasome, NLRP3, PKR, retinal endothelial cells
format article
author Jiang Y
Steinle JJ
author_facet Jiang Y
Steinle JJ
author_sort Jiang Y
title Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
title_short Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
title_full Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
title_fullStr Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
title_full_unstemmed Epac1 inhibits PKR to reduce NLRP3 inflammasome proteins in retinal endothelial cells
title_sort epac1 inhibits pkr to reduce nlrp3 inflammasome proteins in retinal endothelial cells
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/de5c849afd984451972265bd3eae937e
work_keys_str_mv AT jiangy epac1inhibitspkrtoreducenlrp3inflammasomeproteinsinretinalendothelialcells
AT steinlejj epac1inhibitspkrtoreducenlrp3inflammasomeproteinsinretinalendothelialcells
_version_ 1718401950263803904